EUVIMEDEUVIMED entdecken
Crossref

Conversion surgery for initially unresectable hepatocellular carcinoma after nivolumab plus ipilimumab: pathological complete response in the resected lesions

Takeshi Koujima, Toshifumi Tada, Emi Tanaka, Shinichiro Nakamura, Shohei Yokoyama, Takuro Fushimi, Yoshikatsu Endo, Minami Kakiuchi, Kyohei Kai

Clinical Journal of Gastroenterology · 17.11.2026

DOI: 10.1007/s12328-026-02489-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Journal of Gastroenterology, online erschienen am 17.11.2026. Verfasst von Takeshi Koujima und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Japanese Red Cross Society Himeji Hospital, 1-12-1 Shimoteno, Himeji, Hyogo, 670-8540, Japan. takeshi.kj.56@gmail.com. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Conversion surgery for initially unresectable hepatocellular carcinoma has become increasingly feasible with the introduction of immune checkpoint inhibitors, although published cases remain limited because these therapies have only recently entered clinical practice. We report a 70 year-old man with initially unresectable hepatocellular carcinoma (HCC). The largest tumor measured 9.0 × 6.0 cm in segments 7/8, accompanied by multiple additional intrahepatic lesions. The patient received nivolumab plus ipilimumab. After seven treatment cycles, the dominant lesion had decreased to 6.0 × 4.0 cm, and only four intrahepatic nodules remained identifiable. Arterial enhancement disappeared from all residual lesions, corresponding to a complete response according to modified Response Evaluation Criteria in Solid Tumors (mRECIST). Serum alpha-fetoprotein and des-γ-carboxyprothrombin levels normalized and remained within the normal range. The patient subsequently underwent conversion surgery consisting of right hepatectomy and partial hepatectomy of the Spiegel lobe. Histopathological examination revealed complete necrosis without viable cancer cells in all resected lesions, confirming a pathological complete response in the resected lesions. Because two segment 4 lesions that had disappeared radiologically were not resected, pathological complete response of the entire pretreatment tumor burden could not be confirmed. This case illustrates that nivolumab plus ipilimumab may downstage initially unresectable HCC and enable curative-intent conversion surgery in selected patients.

Schlagwörter

Stichwörter der Autor:innen

Conversion surgeryHepatocellular carcinomaIpilimumabNivolumabPathological complete response

Autor:innen und Institutionen

  • Department of Surgery, Japanese Red Cross Society Himeji Hospital, 1-12-1 Shimoteno, Himeji, Hyogo, 670-8540, Japan. takeshi.kj.56@gmail.com.
  • Division of Gastroenterology, Department of Internal Medicine, Japanese Red Cross Society Himeji Hospital, Himeji, Japan.
  • Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Department of Surgery, Japanese Red Cross Society Himeji Hospital, 1-12-1 Shimoteno, Himeji, Hyogo, 670-8540, Japan.
  • Department of Pathology, Japanese Red Cross Society Himeji Hospital, Himeji, Japan.

Zitieren

APA

Koujima, T., Tada, T., Tanaka, E., Nakamura, S., Yokoyama, S., Fushimi, T., Endo, Y., Kakiuchi, M., & Kai, K. (2026). Conversion surgery for initially unresectable hepatocellular carcinoma after nivolumab plus ipilimumab: pathological complete response in the resected lesions. Clinical Journal of Gastroenterology. https://doi.org/10.1007/s12328-026-02489-9

Vancouver

Koujima T, Tada T, Tanaka E, Nakamura S, Yokoyama S, Fushimi T, et al. Conversion surgery for initially unresectable hepatocellular carcinoma after nivolumab plus ipilimumab: pathological complete response in the resected lesions. Clinical Journal of Gastroenterology. 2026. doi:10.1007/s12328-026-02489-9

BibTeX
@article{Koujima2026,
  author = {Koujima, Takeshi and Tada, Toshifumi and Tanaka, Emi and Nakamura, Shinichiro and Yokoyama, Shohei and Fushimi, Takuro and Endo, Yoshikatsu and Kakiuchi, Minami and Kai, Kyohei},
  title = {Conversion surgery for initially unresectable hepatocellular carcinoma after nivolumab plus ipilimumab: pathological complete response in the resected lesions},
  journal = {Clinical Journal of Gastroenterology},
  year = {2026},
  doi = {10.1007/s12328-026-02489-9}
}
Kostenlos starten →